Page last updated: 2024-10-28

hydralazine and Abnormality, Heart

hydralazine has been researched along with Abnormality, Heart in 3 studies

Hydralazine: A direct-acting vasodilator that is used as an antihypertensive agent.
hydralazine : The 1-hydrazino derivative of phthalazine; a direct-acting vasodilator that is used as an antihypertensive agent.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19902 (66.67)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Olson-Chen, C1
Seligman, NS1
Artman, M1
Parrish, MD1
Graham, TP1
Fripp, RR1
Gewitz, MH1
Werner, JC1
Whitman, V1
Rashkind, WJ1

Reviews

2 reviews available for hydralazine and Abnormality, Heart

ArticleYear
Hypertensive Emergencies in Pregnancy.
    Critical care clinics, 2016, Volume: 32, Issue:1

    Topics: Antihypertensive Agents; Cesarean Section; Chronic Disease; Congenital Abnormalities; Emergencies; E

2016
Congestive heart failure in childhood and adolescence: recognition and management.
    American heart journal, 1983, Volume: 105, Issue:3

    Topics: Adolescent; Captopril; Cardiomyopathies; Child; Digoxin; Dobutamine; Dopamine; Echocardiography; Ele

1983

Other Studies

1 other study available for hydralazine and Abnormality, Heart

ArticleYear
Oral hydralazine in patients with pulmonary vascular disease secondary to congenital heart disease.
    The American journal of cardiology, 1981, Volume: 48, Issue:2

    Topics: Administration, Oral; Cardiac Output; Child; Child, Preschool; Female; Heart Defects, Congenital; He

1981